Browse by author
Lookup NU author(s): Dr Quentin Campbell Hewson,
Professor Penny Lovat,
Professor Andrew Pearson,
Dr Chris RedfernORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
9-cis Retinoic acid (RA) induces gene expression in neuroblastoma cells more effectively and with different kinetics than other RA isomers, and could be acting in part through Retinoid X Receptors (RXRs). The aim of this study was to characterise the effects of an RXR agonist and RXR homodimer antagonist on the induction of cellular RA binding protein II (CRABP-II) and RA receptor-β (RARβ) in neuroblastoma cells in response to different retinoids. The RXR agonist, LDG1069, was as effective as all-trans RA in inducing gene expression, but less effective than 9-cis RA. The RXR-homodimer antagonist, LG100754, inhibited the induction of CRABP-II mRNA in SH-SY5Y neuroblastoma cells by 9-cis RA or the RXR-specific agonist LGD1069, but had no effect when used with all-trans RA. Conversely, LG100754 did not inhibit induction of RARβ mRNA by 9-cis or all-trans RA, or by LGD1069. RAR- and RXR-specific ligands used together induced CRABP-II and RARβ as effectively as 9-cis RA. These results demonstrate the value of combining RXR- and RAR-specific ligands to regulate RA-inducible gene expression. The possibility that RXR-homodimers mediate, in part, the induction of CRABP-II by 9-cis RA and RXR-specific ligands is discussed. © 2002 Wiley-Liss, Inc.
Author(s): Campbell-Hewson, Q., Lovat, P.E., Pearson, A.D.J., Redfern, C.P.F.
Publication type: Article
Publication status: Published
Journal: Journal of Cellular Biochemistry
Print publication date: 01/01/2002
ISSN (print): 0730-2312
ISSN (electronic): 1097-4644
PubMed id: 12397610
Altmetrics provided by Altmetric